Dr Jonathan Snicker
Executive Chair and Chief Strategy Officer
20+ years’ experience in variety of Board and Executive roles spanning, business development, philanthropy, university academia, strategic, political, comms and funding advisory.
Prof. Andrew Shaw
CEO & Founder
Attomarker is Prof Shaw’s second spinout company, the first having been sold for $8M. He will move to Chief Scientist when the next round is closed.
Sakura Holloway
NED, BIF Opportunities LP
Sakura represents Future Planet Capital as Portfolio Manager for their BIF Opportunities Fund, a specialist Life Sciences and AgTech venture capital fund investing in UK university spinouts at Series A/B stage.
Sandy Primrose
NED
Experienced Biotech entrepreneur as Chair and Director for many companies leading to trade sales
Yves Le Goff
Strategic Adviser and CCO, EU Markets
Yves co-led Attomarker’s GBP1.5m Future Fund 2020 funding round. He is a former investment banker (Goldman Sachs, Credit Suisse) and early-stage investor
Robert Warner
CFO
Chartered Accountant from KPMG, with 20 years’ experience as a commercial CFO, gained across a variety of rapid-scale international businesses in diverse sectors
Chandru R. Chandrasekar
Director of International Development
Chandru is an investor and former orthopaedic surgeon with deep connections in India and Singapore, with a mission to nurture sustainable technology platforms at ‘India Scale, India Price’.
Steve Brine
Advisor
Former MP, Health Minister and Chair of the cross-party Commons Health Select Committee, Steve is an authoritative voice on public health, healthcare innovation, and the prevention of ill health.
Dr Shivali Kohli
Director of Products
With a PhD in neuropharmacology and 10+ years in scientific research at leading universities, she brings a wealth of experience in project and team management.
Dr Philip James-Pemberton
Director of Research
Philip James-Pemberton leads the development of innovative diagnostic technologies. With a background in biomedical research and extensive experience in nanophotonic testing, he specialises in translating cutting-edge science into practical healthcare solutions. Philip plays a key role in advancing rapid, precise diagnostics for real-world applications.
